Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Helsekosten Viborg ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 5.8% 5.8%   Bankruptcy risk   8.8% 3.6% 8.0% 10.3% 11.9% 12.8% 14.7% 14.5%   Credit score (0-100)   29 54 30 22 19 14 2 2   Credit rating   B BB B B B B B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,002 1,175 1,077 924 728 640 0.0 0.0   EBITDA   36.3 284 116 38.2 -28.8 -46.6 0.0 0.0   EBIT   -56.3 191 22.7 -55.4 -113 -73.7 0.0 0.0   Pre-tax profit (PTP)   -108.7 145.5 -16.5 -92.4 -146.5 -128.3 0.0 0.0   Net earnings   -85.2 112.7 -12.9 -72.1 -114.3 -100.1 0.0 0.0   Pre-tax profit without non-rec. items   -109 145 -16.5 -92.4 -147 -128 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   456 372 289 205 130 102 0.0 0.0   Shareholders equity total   -94.3 18.4 5.6 -66.5 -181 -281 -331 -331   Interest-bearing liabilities   781 722 660 595 623 702 331 331   Balance sheet total (assets)   1,297 1,213 1,491 1,069 850 931 0.0 0.0   Net Debt   694 631 334 501 620 699 331 331     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,002 1,175 1,077 924 728 640 0.0 0.0   Gross profit growth   738.4% 17.2% -8.3% -14.2% -21.2% -12.0% -100.0% 0.0%   Employees   2 3 3 3 3 3 0 0   Employee growth %   0.0% 50.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,297 1,213 1,491 1,069 850 931 0 0   Balance sheet change%   -2.4% -6.5% 22.9% -28.3% -20.4% 9.5% -100.0% 0.0%   Added value   36.3 284.2 116.2 38.2 -19.2 -46.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -142 -187 -187 -187 -168 -54 -102 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -5.6% 16.2% 2.1% -6.0% -15.5% -11.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -4.1% 14.6% 1.7% -4.2% -10.4% -6.6% 0.0% 0.0%   ROI %   -7.1% 24.5% 2.9% -8.1% -18.5% -11.1% 0.0% 0.0%   ROE %   -6.5% 17.1% -107.4% -13.4% -11.9% -11.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -6.8% 1.5% 0.4% -5.9% -17.5% -23.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,911.7% 222.0% 287.6% 1,312.1% -2,154.3% -1,501.1% 0.0% 0.0%   Gearing %   -828.3% 3,919.5% 11,888.2% -894.7% -344.7% -249.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.6% 6.0% 5.7% 5.9% 5.5% 8.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.4 0.7 0.4 0.2 0.3 0.0 0.0   Current Ratio   1.1 1.5 1.4 1.3 1.1 0.9 0.0 0.0   Cash and cash equivalent   87.0 91.4 326.1 94.1 3.0 3.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   69.3 243.1 323.1 179.3 79.4 -82.1 -165.4 -165.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   18 95 39 13 -6 -16 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   18 95 39 13 -10 -16 0 0   EBIT / employee   -28 64 8 -18 -38 -25 0 0   Net earnings / employee   -43 38 -4 -24 -38 -33 0 0